Request Clinical Starter Kits for Your Patients Today! Request Now

 Blood Sugar and Insulin STUDIES

Berberine and other sustained-release nutrients provide more complete support for diabetes treatment, mini-review shows

Highlights Oxidative/nitrosative (O/N) stress is a causative factor in prediabetes and diabetes Metformin and other standard drugs fail to address O/N stress Key dietary supplements can help combat O/N stress...
on February 25, 2020

Alpha lipoic acid improves measures of neuropathy in people with diabetes, study shows

Highlights Multi-center, randomized, double-blind, placebo-controlled trial Participants include 460 patients with diabetes and mild-to-moderate polyneuropathy Supplementation consists of ALA (600 mg/day) for 4 years ALA has no effect on a...
on February 25, 2020

Alpha lipoic acid helps relieve symptoms of diabetic polyneuropathy, review shows

Highlights Assessment includes 5 randomized, double-blind, placebo-controlled trials with 1,160 subjects Alpha lipoic acid shown to provide symptomatic relief of diabetic polyneuropathy Effect oral dosage is 600 mg/day for up...
on February 25, 2020

Alpha lipoic acid benefits people with metabolic diseases, meta-analysis shows

Highlights Meta-analysis of 24 randomized, controlled trials with patients with metabolic diseases ALA supplementation ranges from 200 to 1,800 mg/day Study duration ranges from 2 to 51 weeks ALA supplementation significantly improves glycemic...
on February 25, 2020

Alpha lipoic acid benefits for diabetic neuropathy are better for some patients, study shows

Highlights Post-hoc analysis of the NATHAN 1 trial Participants include 460 patients with diabetes and mild-to-moderate polyneuropathy Supplementation consists of ALA (600 mg/day) for 4 years ALA treatment is particularly...
on February 25, 2020
"